Simplified Chinese
Overseas market
Release date:
2018-07-02
Author:
Source:
Abstract
The company’s products are steadily expanding beyond China and gaining global recognition, including its independently developed acellular pertussis–diphtheria–tetanus vaccine. b Haemophilus influenzae type b conjugate vaccine, measles–rubella combined vaccine, 23 Pneumococcal polysaccharide vaccine 23 Pneumococcal polysaccharide vaccine, ACYW135 Meningococcal conjugate vaccine, tetanus antitoxin, and measles–rubella semi‑finished product, 23 Semi-finished products of pneumococcal polysaccharide vaccine, measles concentrate, and others are currently… 40 Registered in multiple countries, it can serve approximately… in India, Pakistan, Bangladesh, Indonesia, Russia, Nigeria, and other nations. 25 Providing immunization services to hundreds of millions of people.

Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09